$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2022 Q1 Form 10-Q Financial Statement

#000141057822000149 Filed on February 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $4.291M $5.319M $5.272M
YoY Change 43.15% 3.79% -18.35%
Cost Of Revenue $2.809M $3.602M $3.696M
YoY Change 36.44% -0.06% -15.1%
Gross Profit $1.481M $1.717M $1.576M
YoY Change 57.86% 12.91% -25.09%
Gross Profit Margin 34.52% 32.27% 29.9%
Selling, General & Admin $1.464M $1.570M $1.357M
YoY Change 0.15% 18.8% 7.35%
% of Gross Profit 98.87% 91.44% 86.1%
Research & Development $142.7K $97.37K $97.07K
YoY Change 2.46% -8.67% 5.8%
% of Gross Profit 9.63% 5.67% 6.16%
Depreciation & Amortization $730.00 $770.00 $4.270K
YoY Change -99.54% -54.44% 96.77%
% of Gross Profit 0.05% 0.04% 0.27%
Operating Expenses $1.607M $1.667M $1.454M
YoY Change 0.35% 16.75% 7.24%
Operating Profit -$126.0K $49.51K $122.0K
YoY Change -81.01% -46.42% -83.69%
Interest Expense -$109.9K $14.16K $14.31K
YoY Change 633.09% 0.5% -35.61%
% of Operating Profit 28.59% 11.73%
Other Income/Expense, Net
YoY Change
Pretax Income -$235.8K $35.35K $107.7K
YoY Change -48.38% -54.86% -85.16%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$235.8K $35.35K $107.7K
YoY Change -48.38% -54.86% -85.16%
Net Earnings / Revenue -5.5% 0.66% 2.04%
Basic Earnings Per Share $0.02 $0.05
Diluted Earnings Per Share -$102.0K $0.02 $0.05
COMMON SHARES
Basic Shares Outstanding 2.313M 2.313M 2.313M
Diluted Shares Outstanding 2.313M 2.313M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $438.7K $387.2K $168.6K
YoY Change 173.19% -33.34% 15.15%
Cash & Equivalents $438.7K $387.2K $168.6K
Short-Term Investments
Other Short-Term Assets $241.3K $202.7K $529.2K
YoY Change -28.32% 13.53% 226.55%
Inventory $6.229M $5.123M $4.966M
Prepaid Expenses $241.3K $202.7K $529.2K
Receivables $1.290M $878.0K $302.4K
Other Receivables $2.800M $3.363M $3.580M
Total Short-Term Assets $11.00M $9.954M $9.546M
YoY Change 51.46% 37.05% 13.75%
LONG-TERM ASSETS
Property, Plant & Equipment $477.6K $53.92K $97.51K
YoY Change 158.63% -76.05% -63.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $521.9K $99.28K $144.0K
YoY Change 123.6% -63.89% -54.51%
TOTAL ASSETS
Total Short-Term Assets $11.00M $9.954M $9.546M
Total Long-Term Assets $521.9K $99.28K $144.0K
Total Assets $11.52M $10.05M $9.690M
YoY Change 53.71% 33.37% 11.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.572M $443.0K $396.4K
YoY Change 208.57% -22.16% -29.22%
Accrued Expenses $751.4K $295.1K $285.0K
YoY Change 81.6% -34.29% -44.62%
Deferred Revenue
YoY Change
Short-Term Debt $3.239M $3.439M $3.495M
YoY Change 17035.08% 1453.24% 153.22%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.547M $5.179M $4.852M
YoY Change 285.74% 317.81% 97.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $335.4K $0.00
YoY Change -68.98% -100.0%
Total Long-Term Liabilities $335.4K $0.00 $0.00
YoY Change -68.98% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.547M $5.179M $4.852M
Total Long-Term Liabilities $335.4K $0.00 $0.00
Total Liabilities $6.883M $5.179M $4.852M
YoY Change 147.69% 119.03% 34.24%
SHAREHOLDERS EQUITY
Retained Earnings -$8.271M -$8.035M -$8.070M
YoY Change 0.95%
Common Stock $12.91M $12.91M $12.91M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.638M $4.874M $4.839M
YoY Change
Total Liabilities & Shareholders Equity $11.52M $10.05M $9.690M
YoY Change 53.71% 33.37% 11.27%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$235.8K $35.35K $107.7K
YoY Change -48.38% -54.86% -85.16%
Depreciation, Depletion And Amortization $730.00 $770.00 $4.270K
YoY Change -99.54% -54.44% 96.77%
Cash From Operating Activities $251.9K $274.7K -$2.190M
YoY Change -157.34% -82.76% 326.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.3K -56.01K 2.308M
YoY Change -1159.49% -95.17% 505.64%
NET CHANGE
Cash From Operating Activities 251.9K 274.7K -2.190M
Cash From Investing Activities
Cash From Financing Activities -200.3K -56.01K 2.308M
Net Change In Cash 51.51K 218.7K 118.2K
YoY Change -112.26% -49.68% -189.65%
FREE CASH FLOW
Cash From Operating Activities $251.9K $274.7K -$2.190M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
UUU
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
387223
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
160604
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
877960
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
653172
CY2021Q4 uuu Receivables From Employees
ReceivablesFromEmployees
7250
CY2021Q1 uuu Receivables From Employees
ReceivablesFromEmployees
5000
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
885210
CY2021Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
658172
CY2021Q4 uuu Due From Factor
DueFromFactor
3355802
CY2021Q1 uuu Due From Factor
DueFromFactor
1925291
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Inventory Net
InventoryNet
5123468
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2021Q1 us-gaap Inventory Net
InventoryNet
4181193
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
202669
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
336699
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9954372
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2021Q1 us-gaap Assets Current
AssetsCurrent
7261959
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53920
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
184678
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
41363
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44717
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Amendment Flag
AmendmentFlag
false
us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31747
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0898545
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Gross Profit
GrossProfit
4551126
us-gaap Gross Profit
GrossProfit
4701494
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4059988
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3572189
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
295496
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
332276
us-gaap Operating Income Loss
OperatingIncomeLoss
195642
us-gaap Operating Income Loss
OperatingIncomeLoss
797029
us-gaap Interest Expense
InterestExpense
37954
us-gaap Interest Expense
InterestExpense
71848
us-gaap Net Income Loss
NetIncomeLoss
157688
us-gaap Net Income Loss
NetIncomeLoss
725181
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Address Address Line1
EntityAddressAddressLine1
11407 Cronhill Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Owings Mills
dei Entity Address Country
EntityAddressCountry
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21117
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
363-3000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Assets
Assets
10053655
CY2021Q1 us-gaap Assets
Assets
7495354
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2357431
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
18904
CY2021Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
1081440
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43965
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171122
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
443032
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
509561
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1002385
CY2021Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
755148
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
139217
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103381
CY2021Q4 uuu Commissions And Other
CommissionsAndOther
111941
CY2021Q1 uuu Commissions And Other
CommissionsAndOther
139242
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5179411
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1697358
CY2021Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1081440
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1081440
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
14641
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Revenues
Revenues
15259235
us-gaap Revenues
Revenues
14522813
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
10708109
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
9821319
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
23129
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8034726
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8192414
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4874244
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10053655
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7495354
CY2021Q4 us-gaap Revenues
Revenues
5319014
CY2020Q4 us-gaap Revenues
Revenues
5124750
CY2021Q4 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
3602391
CY2020Q4 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
3604427
CY2021Q4 us-gaap Gross Profit
GrossProfit
1716623
CY2020Q4 us-gaap Gross Profit
GrossProfit
1520323
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1569746
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1321311
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97370
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106608
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
49507
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
92404
CY2021Q4 us-gaap Interest Expense
InterestExpense
14156
CY2020Q4 us-gaap Interest Expense
InterestExpense
14086
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
35351
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
78318
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4874244
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4369231
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4731197
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
107696
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4838893
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
35351
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4448213
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-78982
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
725845
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5095076
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
78318
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5173394
us-gaap Net Income Loss
NetIncomeLoss
157688
us-gaap Net Income Loss
NetIncomeLoss
725181
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6955
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6532
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1657549
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1017400
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
808245
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
-2018807
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
189243
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
94255
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2111908
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1827375
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2338527
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1561665
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
221400
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2338527
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1340265
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
226619
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
487110
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160604
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93794
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
387223
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
580904
us-gaap Interest Paid Net
InterestPaidNet
37954
us-gaap Interest Paid Net
InterestPaidNet
68174
uuu Non Cash Conversion Of Trade Accounts Payable To Note Payable
NonCashConversionOfTradeAccountsPayableToNotePayable
1081440
CY2020Q3 uuu Minimum Amount Of Stockholder S Equity After Reporting Loss From Operations
MinimumAmountOfStockholderSEquityAfterReportingLossFromOperations
6000000.0
CY2021Q4 uuu Trade Accounts Receivable Net
TradeAccountsReceivableNet
878000
CY2015Q1 uuu Percentage Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.80
CY2015Q1 uuu Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
1
CY2015Q1 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2015Q1 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
500000
CY2021Q3 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2021Q3 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
1500000
uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
CY2021Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2357000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
383000
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.02
CY2021Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0525
CY2021Q4 us-gaap Revenues
Revenues
5319014
CY2020Q4 us-gaap Revenues
Revenues
5124750
us-gaap Revenues
Revenues
15259235
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
134329
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
us-gaap Revenues
Revenues
14522813
CY2021Q4 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
509000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
1332000
CY2020Q4 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
379000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
746000
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
210773
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
43965
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P25Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
us-gaap Operating Lease Payments
OperatingLeasePayments
128600
uuu Non Cash Right Of Use Asset In Exchange For Operating Lease Liability
NonCashRightOfUseAssetInExchangeForOperatingLeaseLiability
485000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43965
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44329
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
44329
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
364
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43965

Files In Submission

Name View Source Status
0001410578-22-000149-index-headers.html Edgar Link pending
0001410578-22-000149-index.html Edgar Link pending
0001410578-22-000149.txt Edgar Link pending
0001410578-22-000149-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20211231.xsd Edgar Link pending
uuu-20211231x10q.htm Edgar Link pending
uuu-20211231x10q_htm.xml Edgar Link completed
uuu-20211231xex31d1.htm Edgar Link pending
uuu-20211231xex31d2.htm Edgar Link pending
uuu-20211231xex32d1.htm Edgar Link pending
uuu-20211231xex99d1.htm Edgar Link pending
uuu-20211231xex99d1001.jpg Edgar Link pending
uuu-20211231xex99d1002.jpg Edgar Link pending
uuu-20211231_cal.xml Edgar Link unprocessable
uuu-20211231_def.xml Edgar Link unprocessable
uuu-20211231_lab.xml Edgar Link unprocessable
uuu-20211231_pre.xml Edgar Link unprocessable